Skip to main content
رجوع
LBRX logo

LB Pharmaceuticals Inc Common Stock

جودة البيانات: 100%
LBRX
NASDAQ Healthcare Biotechnology
KWD 24.21
▲ KWD 0.84 (3.59%)
القيمة السوقية: 612.49M
نطاق اليوم
KWD 22.84 KWD 24.60
نطاق 52 أسبوعًا
KWD 13.36 KWD 27.55
حجم التداول
170,855
متوسط 50 يوم / 200 يوم
KWD 23.15 / KWD 19.54
الإغلاق السابق
KWD 23.37

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -9.7 0.3
P/B 3.0
ROE % 3.7
Net Margin % 3.8
Rev Growth 5Y % 10.0
D/E 0.2

السعر المستهدف للمحللين

Hold
KWD 33.33 +37.7%
Low: KWD 31.00 High: KWD 35.00
ربحية السهم المستقبلية
-KWD 4.05
الإيرادات المقدّرة
0.0

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2028 -KWD 4.59
-KWD 6.12 – -KWD 3.05
0.0 2
FY2027 -KWD 3.89
-KWD 4.68 – -KWD 3.10
0.0 2
FY2026 -KWD 4.05
-KWD 5.08 – -KWD 3.25
0.0 3

Earnings Surprises

Last 1 quarter
Quarter Est. EPS Actual EPS Surprise
2025-11-06 -KWD 0.57 -KWD 0.61 -7.0%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Negative free cash flow of -53.82M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio3.56
Interest Coverage0.00

التقييم

P/E Ratio
-9.71
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -63.10M
ROE N/A ROA -188.17%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -53.82M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.56
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9.71 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio 0.00 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.79%
Market Cap 612.49M Enterprise Value 593.22M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 0.0 0.0 0.0
Net Income -63.10M -6.28M -14.35M
EPS (Diluted) -17.83 -1.77 -4.05
Gross Profit 0.0 0.0 0.0
Operating Income -64.83M -11.38M -2.81M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 33.53M 45.66M 21.49M
Total Liabilities 128.09M 80.13M 50.30M
Shareholders' Equity -94.55M -34.47M -28.81M
Total Debt 3.70M 0.0 24.15M
Cash & Equivalents 22.98M 14.98M 21.40M
Current Assets 28.88M 45.63M 21.49M
Current Liabilities 8.11M 2.61M 469,000.0